Abstract
Purpose
To determine whether multi-parametric magnetic resonance imaging (mpMRI) can reliably predict proximity of prostate cancer to the prostatic urethra in a contemporary series of men undergoing radical prostatectomy (RP) at two academic centers.
Methods
Clinical characteristics of consecutive men undergoing pre-operative mpMRI prior to RP and whole-mount axial serial step-sectioned pathology examination at two academic centers between Jun 2016 and Oct 2018 were analyzed retrospectively. Every tumor was characterized by its pathologic minimum distance to the prostatic urethral lumen (pMDUL). Only the cancer closest to the urethra represented the prostatic urethral index lesion. The radiologic minimum distance of the index lesion to the prostatic urethral lumen was measured and noted as ≤ 5 mm versus > 5 mm. The sensitivity, specificity, positive and negative predicting values (PPV and NPV) and area under the receivers operating characteristics curve (AUC) were calculated for performance of mpMRI for predicting pMDUL ≤ 5 mm.
Results
Of the 163 surgical specimens examined, 112 (69%) exhibited a pMDUL ≤ 5 mm. These men had significantly higher grade group (GG) and advanced pathological and clinical stage. The rates of high PI-RADS score and presence of gross extracapsular extension were also significantly greater for the group with pMDUL ≤ 5 mm. The AUC, sensitivity, specificity, PPV, and NPV were 0.641, 51.8, 76.5, 82.9, and 42.4%, respectively, for mpMRI to predict pMDUL < 5 mm.
Conclusions
Nearly 70% of men undergoing RP present with tumor within 5 mm of the prostatic urethra. These tumors present higher risk characteristics, and mpMRI exhibited moderate performance and high PPV in their pre-operative detection. Physicians performing partial gland ablation should take these results into consideration during treatment selection and planning.
Similar content being viewed by others
Code availability
Not applicable.
References
Sanda MG, Cadeddu JA, Kirkby E et al (2018) Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part II: recommended approaches and details of specific care options. J Urol 199(4):990–997
Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J (1993) Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72(4):1291–1299
Donnelly BJ, Saliken JC, Brasher PM et al (2010) A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer 116(2):323–330
Shelley M, Wilt TJ, Coles B, Mason MD (2007) Cryotherapy for localised prostate cancer. Cochrane Database Syst Rev 3:CD005010
Cohen JK, Miller RJ, Shuman BA (1995) Urethral warming catheter for use during cryoablation of the prostate. Urology 45(5):861–864
Padilha MM, Stephen Jones J, Streator Smith K, Zhou M, Walker E, Magi-Galluzzi C (2013) Prediction of prostate cancer to urethra distance by a pretreatment nomogram: urethral thermoprotection implication in cryoablation. Prostate Cancer Prostatic Dis 16(4):372–375
Leibovich BC, Blute ML, Bostwick DG et al (2000) Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies. Urology 56(5):726–729
Futterer JJ, Briganti A, De Visschere P et al (2015) Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature. Eur Urol 68(6):1045–1053
Mendhiratta N, Meng X, Rosenkrantz AB et al (2015) Prebiopsy MRI and MRI-ultrasound fusion-targeted prostate biopsy in men with previous negative biopsies: impact on repeat biopsy strategies. Urology 86(6):1192–1198
Chong Y, Kim CK, Park SY, Park BK, Kwon GY, Park JJ (2014) Value of diffusion-weighted imaging at 3 T for prediction of extracapsular extension in patients with prostate cancer: a preliminary study. AJR Am J Roentgenol 202(4):772–777
Kenigsberg AP, Tamada T, Rosenkrantz AB et al (2018) Multiparametric magnetic resonance imaging identifies significant apical prostate cancers. BJU international 121(2):239–243
Samaratunga H, Montironi R, True L et al (2011) International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 1: specimen handling. Mod Pathol 24(1):6–15
Huang CC, Deng FM, Kong MX, Ren Q, Melamed J, Zhou M (2014) Re-evaluating the concept of “dominant/index tumor nodule” in multifocal prostate cancer. Virchows Arch 464(5):589–594
Weinreb JC, Barentsz JO, Choyke PL et al (2016) PI-RADS prostate imaging-reporting and data system: 2015, version 2. Eur Urol 69(1):16–40
Ficarra V, Novara G, Ahlering TE et al (2012) Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur Urol 62(3):418–430
Ficarra V, Novara G, Rosen RC et al (2012) Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol 62(3):405–417
Mungovan SF, Sandhu JS, Akin O, Smart NA, Graham PL, Patel MI (2017) Preoperative membranous urethral length measurement and continence recovery following radical prostatectomy: a systematic review and meta-analysis. Eur Urol 71(3):368–378
Feng TS, Sharif-Afshar AR, Wu J et al (2015) Multiparametric MRI improves accuracy of clinical nomograms for predicting extracapsular extension of prostate cancer. Urology 86(2):332–337
Marenco J, Orczyk C, Collins T, Moore C, Emberton M (2019) Role of MRI in planning radical prostatectomy: what is the added value? World J Urol 37(7):1289–1292
Favazza C, Gorny K, King D et al (2014) An investigation of the effects from a urethral warming system on temperature distributions during cryoablation treatment of the prostate: a phantom study. Cryobiology 69(1):128–133
Crawford ED, Abrahamsson P-A (2008) PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Eur Urol 54(2):262–273
Allen ZA, Merrick GS, Butler WM et al (2005) Detailed urethral dosimetry in the evaluation of prostate brachytherapy-related urinary morbidity. Int J Radiat Oncol Biol Phys 62(4):981–987
Vainshtein J, Abu-Isa E, Olson KB et al (2012) Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy. Radiat Oncol 7:82
Repka MC, Guleria S, Cyr RA et al (2016) Acute urinary morbidity following stereotactic body radiation therapy for prostate cancer with prophylactic alpha-adrenergic antagonist and urethral dose reduction. Front Oncol 6:122
Funding
No funding was required for the development of this study.
Author information
Authors and Affiliations
Contributions
BE: project development and manuscript writing. SA: data analysis. AA: project development. IT: data analysis. TA: data collection. DFM: data collection. IA: data analysis. GC: data collection. GI: project development. AM: data collection. PS: data collection. LH: project development.
Corresponding author
Ethics declarations
Conflict of interest
AA: Consultant for Koelis and was proctor in training for Steba Biotech.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Becher, E., Sali, A., Abreu, A. et al. MRI predicts prostatic urethral involvement in men undergoing radical prostatectomy: implications for cryo-ablation of localized prostate cancer. World J Urol 39, 3309–3314 (2021). https://doi.org/10.1007/s00345-020-03566-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-020-03566-5